Sms Pharmaceuticals Ltd. | Small-cap | Healthcare
₹239.10
2.09%
| Sms Pharmaceuticals Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 7.8B
Gross Profit 2.6B 33.13%
Operating Income 1.0B 13.37%
Net Income 691.4M 8.83%

Balance Sheet Metrics

Total Assets 11.5B
Total Liabilities 5.1B
Shareholders Equity 6.4B
Debt to Equity 0.80

Cash Flow Metrics

Operating Cash Flow 1.0B
Free Cash Flow -416.7M

Revenue & Profitability Trend

Sms Pharmaceuticals Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 7.8B 7.1B 5.2B 5.2B 5.6B
Cost of Goods Sold 5.2B 5.0B 3.9B 3.3B 3.8B
Gross Profit 2.6B 2.1B 1.3B 1.8B 1.8B
Operating Expenses 402.6M 305.7M 229.3M 129.2M 127.8M
Operating Income 1.0B 852.5M 224.8M 824.7M 988.6M
Pre-tax Income 923.4M 661.1M 53.5M 685.0M 911.2M
Income Tax 249.4M 169.1M 14.6M 6.2M 301.6M
Net Income 691.4M 498.3M -70.6M 622.2M 625.3M
EPS (Diluted) - ₹5.89 -₹0.83 ₹7.35 ₹7.39

Income Statement Trend

Sms Pharmaceuticals Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 5.5B 5.3B 4.1B 3.8B 3.1B
Non-Current Assets 6.0B 5.0B 4.7B 4.8B 5.0B
Total Assets 11.5B 10.3B 8.8B 8.6B 8.1B
Liabilities
Current Liabilities 3.2B 3.3B 2.5B 2.0B 2.0B
Non-Current Liabilities 1.9B 1.7B 1.6B 1.9B 2.1B
Total Liabilities 5.1B 5.0B 4.2B 3.9B 4.0B
Equity
Total Shareholders Equity 6.4B 5.4B 4.6B 4.7B 4.1B

Balance Sheet Composition

Sms Pharmaceuticals Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 923.4M 661.1M 53.5M 685.0M 911.2M
Operating Cash Flow 1.0B -141.5M -507.2M 217.6M 630.3M
Investing Activities
Capital Expenditures -1.2B -520.7M -296.6M -272.3M -1.5B
Investing Cash Flow -1.2B -522.3M -299.1M -274.3M -1.5B
Financing Activities
Dividends Paid -33.9M -25.4M -25.4M -25.4M -
Financing Cash Flow 651.3M 534.7M -103.1M 30.3M 961.4M
Free Cash Flow -416.7M -20.4M -74.7M 178.1M -613.0M

Cash Flow Trend

Sms Pharmaceuticals Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.36
Price to Book 3.21
Price to Sales 2.62

Profitability Ratios

Profit Margin 8.83%
Operating Margin 12.96%
Return on Equity 11.76%
Return on Assets 5.98%

Financial Health

Current Ratio 1.71
Debt to Equity 48.58
Beta 0.70

Per Share Data

EPS (TTM) ₹8.17
Book Value per Share ₹72.15
Revenue per Share ₹92.39

Financial data is updated regularly. All figures are in the company's reporting currency.